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We recently discovered that housing adult male
or female rats on ground corncob bedding
blocks male and female sexual behavior and
cyclicity (Markaverich et al. 2002b). These
results suggested that this bedding material
contained endocrine-disruptive substances. We
initially postulated that the endocrine-disrup-
tive agent(s) in corncob was likely a phyto-
estrogen because earlier studies demonstrated
that plant isoflavonoids possess estrogenic
activity in a variety of experimental systems
(Adlercreutz et al. 1992; Bickoff et al. 1958;
Markaverich et al. 1995; Martin et al. 1978).
On the basis of these observations, we rea-
soned that the MCF-7 human breast cancer
cell proliferation (the E-Screen) assay (Soto
et al. 1995) would be a suitable rapid in vitro
screen for the endocrine disruptors in extracts
of ground corncob bedding. Our initial studies
on ground corncob bedding extracts led to the
puriﬁcation of two peaks of mitogenic activity
on reverse-phase high-performance liquid
chromatography (HPLC). Peak I was puriﬁed
to homogeneity and identiﬁed as an isomeric
mixture of 9,12-oxy-10,13-dihydroxyocta-
decanoic acid and 10,13-oxy-9,12-dihydroxy-
octadecanoic acid [tetrahydrofurandiols
(THF-diols)] (Markaverich et al. 2002a). The
compounds (Figure 1) were synthesized and
found to stimulate MCF-7 human breast can-
cer proliferation in vitro and block sexual
behavior in male rats (Mani et al. 2005) and
female rats and ovarian cyclicity (Mani et al.
2005; Markaverich et al. 2002b) at concentra-
tions approximately 200-fold lower than
classical phytoestrogens (Markaverich et al.
1995). In addition, the THF-diols are appar-
ently devoid of estrogenic activity and do not
bind to the estrogen receptor (ER) or nuclear
type II [3H]estradiol binding sites (Markaverich
et al. 2002a, 2002b). Thus, the THF-diols
were identiﬁed as very active endocrine-disrup-
tive agents that block steroid-hormone–depen-
dent pathways through a nonconventional
mechanism.
In this article we describe the puriﬁcation
of the peak II component by HPLC and its
identification by gas chromatography–mass
spectrometry (GC-MS). Synthetic isomeric
preparations of the compound stimulated
breast cancer cell proliferation and blocked
estrous cyclicity in female rats but were devoid
of biologic effects on male sexual behavior.
Like the THF-diols, this novel endocrine-dis-
ruptive agent derived from fatty acid metabo-
lism in plants does not bind to ER or nuclear
type II [3H]estradiol binding sites and thus
antagonizes estrogenic response through non-
classical pathways (Maggiolini et al. 2001;
Markaverich et al. 1988). The studies empha-
size the importance of considering the effects
of the environmental housing conditions on
experimental model systems and also indicate
that human exposure to corncob mitogens
with “endocrine-disruptive potential” could
represent a signiﬁcant human health problem.
Materials and Methods
Animals and treatment. We used adult
(60-day-old) Sprague-Dawley male and female
rats (Harlan Laboratories, Madison, WI) for
these studies. Animals were housed in sus-
pended stainless steel wire cages and main-
tained in compliance with federal guidelines
for animal care (Human Health Extension Act
of 1985, Public Law 99-158) with appropriate
institutional animal care and use committee
approval and were treated humanely with
regard for alleviation of suffering. Rats were
maintained under climate-controlled condi-
tions on a 12-hr light/dark cycle (lights on at
0600 hr) with food (Harlan Teklad Global
Diet no. 2014 containing no alfalfa, soybean,
or phytoestrogen components; Harlan Teklad,
Madison, WI) and water provided ad libitum.
Male and female rats were acclimated to this
environment for at least 3 weeks before the
initiation of the studies.
For the cycling studies, daily vaginal
smears were collected from eight adult female
rats housed under standard conditions and
given tap water containing 2% Tween 80 vehi-
cle as a drinking solution for 30 days to estab-
lish baseline controls and confirm that the
animals were cycling in a normal fashion. This
vehicle has no significant effects on ovarian
cyclicity in rats or on male or female sexual
behavior relative to tap water controls (Mani
et al. 2005; Markaverich et al. 1988, 2002a,
2002b). On day 31, the cycling female rats
were given a 1:1 mixture of the 9,10-dihy-
droxy-12-octadecenoic acid [leukotoxin diol
(LTX-diol)] isomers (2 µg/mL) in the tap
water–Tween 80 vehicle for an additional
30 days. This dose was chosen on the basis of
previous published studies with the THF-diols,
which are structurally similar to the LTX-diols
(Figure 1) and which we suspected would
have similar biologic activities. Daily vaginal
smears were collected throughout the 30-day
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Previous studies in our laboratory demonstrated that high-performance liquid chromatography
(HPLC) analysis of ground corncob bedding extracts characterized two components (peak I and
peak II) that disrupted endocrine function in male and female rats and stimulated breast and
prostate cancer cell proliferation in vitro and in vivo. The active substances in peak I were identiﬁed
as an isomeric mixture of 9,12-oxy-10,13-dihydroxyoctadecanoic acid and 10,13-oxy-9,12-
dihydroxyoctadecanoic acid, collectively designated tetrahydrofurandiols (THF-diols). Studies pre-
sented here describe the purification and identification of the HPLC peak II component as
9,10-dihydroxy-12-octadecenoic acid (leukotoxin diol; LTX-diol), a well-known leukotoxin. A syn-
thetic mixture of LTX-diol and 12,13-dihydroxy-9-octadecenoic acid (iso-leukotoxin diol; i-LTX-
diol) isomers was separated by HPLC, and each isomer stimulated (p < 0.001) MCF-7 cell
proliferation in an equivalent fashion. The LTX-diol isomers failed to compete for [3H]estradiol
binding to the estrogen receptor or nuclear type II sites, even though oral administration of very low
doses of these compounds (>> 0.8 mg/kg body weight/day) disrupted estrous cyclicity in female rats.
The LTX-diols did not disrupt male sexual behavior, suggesting that sex differences exist in response
to these endocrine-disruptive agents. Key words: breast cancer, corncob bedding, endocrine disrup-
tor, estrous cycles, leukotoxin diols. Environ Health Perspect 113:1698–1704 (2005).
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previously described (Markaverich et al. 2002a,
2002b). In this particular study, the female rats
served as their own controls because their ovar-
ian cycles were determined before and after
LTX-diol treatment. Previous studies with the
THF-diols demonstrated that equivalent
results are obtained with separate groups of
controls or treated animals or with animals
serving as their own controls (Markaverich
et al. 2002a, 2002b). 
To determine whether the LTX-diols
affect male reproductive function, three repli-
cate studies employing six established adult
male Sprague-Dawley breeder rats were per-
formed as previously reported for the THF-
diols (Mani et al. 2005; Markaverich et al.
1988, 2002a, 2002b). The male breeder rats
who had side litters at least three times were
housed under reversed lighting conditions in
hanging wire cages and were provided a drink-
ing solution containing LTX-diol isomers
(2 µg/mL of drinking solution) for 1–4 weeks.
Sexual behavior was evaluated by examining
the number of mounts, intromissions, ejacula-
tions, ejaculation latencies (in seconds), and
grooming frequencies in a 30-min test period
with each sexually receptive female as per well-
established procedures in our laboratories
(Hull et al. 1990). Ovariectomized steroid-
primed Sprague-Dawley female rats were used
as stimulus animals and were brought into
behavioral estrus by a subcutaneous priming
injection of 2 µg estradiol benzoate in sesame
oil 48 hr before receiving 100 µg progesterone
(subcutaneously), as previously described
(Markaverich et al. 2002b).
Reagents and solvents. We obtained
linoleic acid and m-chloroperoxybenzoic acid
(mCPBA) from Sigma Chemical (St. Louis,
MO). N,O,-bis(trimethylsilyl)trifluoro-
acetamide with 10% trimethyl chlorosilane
(BSTFA) was obtained from Pierce Chemical
(Rockford, IL). We purchased Sep-Pak C18
cartridges (3 cc) from Waters Corporation
(Milford, MA), and C18 minicolumns from
Varian (Walnut Creek, CA). All solvents were
HPLC grade from Burdick and Jackson
(Muskegon, MI).
Purification of peak II from corncob
bedding. We prepared the ethyl acetate extract
of ground corncob bedding as previously
described (Markaverich et al. 2002a, 2002b).
The dried extract was redissolved in approxi-
mately 20 mL HPLC-grade methanol, and
2 mL aliquots were analyzed on a Beckman
Gradient HPLC System (Beckman Coulter,
Fullerton, CA) equipped with a diode array
detector and a Dynamax Ultrasphere-Octyl
HPLC column (Varian). The column was
equilibrated in acetonitrile (CH3CN):water
(30:70) containing 0.1% acetic acid at a ﬂow
rate of 4 mL/min. A linear gradient to 40%
CH3CN was initiated 5 min after injection
and completed by 90 min. Fractions (1 min)
were collected, and triplicate aliquots were
assayed for mitogenic activity in MCF-7
breast cancer cells. 
Mitogenic effects of HPLC fractions and
synthetic LTX-diol on MCF-7 human breast
cancer cells. For the assessment of mitogenic
activities of the various preparations on
MCF-7 cells, we followed previously described
methods (Markaverich et al. 2002a, 2002b).
Briefly, we added the aliquots of the HPLC
fractions (1–5 µL) or HPLC-purified syn-
thetic LTX-diol isomers in redistilled ethanol
to cultured MCF-7 cells grown in phenol
red–free Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing 5% charcoal-stripped,
sulfatase-treated fetal calf serum. Cell number
was determined 7 days after treatment by
hemocytometer counts or by the MTT
(methyl thiazoyl tetrazolium) absorbance
assay (Markaverich et al. 2002a). HPLC frac-
tions containing peak II of mitogenic activity
(Figure 2) were collected on C18 mini-
columns (Varian, Lake Forest, CA) and ana-
lyzed by GC-MS. The mass spectra of the
TMS (trimethylsilylether) derivatives of the
two isomers were in agreement with those
reported in the literature (Halankar et al.
1989). Synthetic LTX-diol and 12,13-dihy-
droxy-9-octadecenoic acid (iso-LTX-diol)
were redissolved in 100% redistilled ethanol
and added to the cultured cells. 
GC-MS studies. For GC-MS analysis, the
HPLC peak components or authentic com-
pounds were derivatized by a number of proce-
dures. We prepared the trimethylsilyl ethers by
adding a 1:4 mixture of BSTFA:CH3CN to
the dried samples, which were vortexed and
heated at 70°C for 30 min. Methyl esters of
the carboxylic acids in the HPLC fractions or
synthetic compounds were prepared by redis-
solving the dried samples in methanol:1 N
HCl (1:3) and heating at 70°C for 60 min.
The samples were taken to dryness under
nitrogen and redissolved in methanol before
analysis. We performed catalytic hydrogena-
tion to reduce double bonds in the unknowns
or synthetic compounds by redissolving the
dried samples in 1 mL methanol in the pres-
ence of a small amount of platinum while bub-
bling H2 gas slowly into the sample to
evaporate the methanol. The dried material
was redissolved in methanol and centrifuged to
remove the platinum pellet. The sample was
transferred to a clean vial and taken to dryness
under nitrogen, and the TMS derivative was
prepared as described above.
The derivatized samples were analyzed on a
Varian 3400 gas chromatograph interfaced
with a Finnigan SSQ 7000 mass spectrometer
(ThermoFinnigan, San Jose, CA) equipped
with a DB-1 column (12.5 m, 0.2 mm inner
diameter, 0.0.33 µm ﬁlm coating; P.J. Cobert,
St. Louis, MO). The initial temperature of
120°C was held for 1 min after sample injec-
tion, increased linearly to 270°C at 10°C/min,
and held at 270°C for 5 min. For electron ion-
ization, the source temperature, electron
energy, and emission current were 200°C,
100 eV, and 300 µA, respectively. For chemi-
cal ionization, the source temperature, electron
energy, and emission current were 140°C,
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Figure 1. Structures of LTX-diols and THF-diols. 
Figure 2. Reverse-phase HPLC of mitogenic activity
from ground corncob bedding. An aliquot (2 mL) of an
ethyl acetate extract of ground corncob bedding was
injected onto a Dynamax C8 column eluted as
described in “Materials and Methods.” and 1-minute
fractions were collected. Aliquots of the fractions
were dried and assayed for mitogenic activity in cul-
tured MCF-7 human breast cancer cells. The peak of
mitogenic activity at approximately 45 min (peak I)
was previously identiﬁed as THF-diols, and the peak
of activity at approximately 70 min (peak II) was col-
lected and analyzed by GC-MS. 240 eV, and 300 µA, respectively. Methane
was used as carrier gas for chemical ionization.
The injector and transfer line temperatures
were 250°C.
Synthesis of 9,10-epoxy-12-octadecenoic
and 12,13-epoxy-9-octadecenoic acids. The
epoxy acids were synthesized from linoleic
acid as previously described (Zheng et al.
2001), with slight modiﬁcations. Linoleic acid
(10 mg) was dissolved in 3 mL methylene
chloride. mCPBA (70 mg) was added to the
sample, and the mixture was stirred at 22°C
for 5 hr. The reaction mixture was washed
sequentially with 1 mL portions of 25 mM
NH4HCO3, saturated saline solution, and
H2O. The washed extract was evaporated to
dryness under N2, and the waxy white solid
was stored at –20°C.
Synthesis and puriﬁcation of LTX-diol and
iso-LTX-diol. Approximately 20 mg of the
waxy white solid described above was dissolved
in THF:H2O:5% perchloric acid (5:1:1) and
stirred at 22°C for 1 hr. The products were
extracted into ethyl acetate and evaporated to
dryness under vacuum. LTX-diol and iso-
LTX-diol were separated from linoleic acid and
THF-diols in these synthetic mixtures by chro-
matography on C18 reverse-phase mini-
columns. To accomplish the separation, the
dry synthetic mixture was redissolved in
approximately 300 µL CH3CN. This solution
was applied to a C18 minicolumn pre-
equilibrated with 2 mL CH3CN and 4 mL
0.5% acetic acid. The column was washed
with 40% CH3CN in 0.5% acetic acid to elute
residual by-products of the mCPBA. The col-
umn was then eluted with 50% CH3CN in
0.5% acetic acid to obtain the THF-diols.
Elution with 60% CH3CN/0.5% acetic acid
facilitated the collection of an isomeric mixture
of LTX-diol and iso-LTX-diol. Linoleic acid
elutes from the C18 minicolumns with higher
concentrations (> 70%) of CH3CN and there-
fore was removed from these LTX-diol prepa-
rations. The identity and purity of the eluents
and contaminants in each of the above frac-
tions were conﬁrmed by GC-MS.
HPLC separation of LTX-diol and iso-
LTX-diol. To compare the biologic activities
of the two isomers, separation of LTX-diol
and iso-LTX-diol was performed on a
Beckman HPLC system equipped with an
Altex Ultrasphere-ODS semipreparative col-
umn (10 mm × 25 cm) (Beckman Coulter)
eluted isocratically with 45% CH3CN con-
taining 0.1% acetic acid at a flow rate of
2.0 mL/min. Compounds were detected at
203 nm with a Beckman diode array detector.
The peaks at 32 and 36 min were conﬁrmed
by GC-MS to be pure iso-LTX-diol and
LTX-diol, respectively.
Effects of LTX-diol and iso-LTX-diol on
MCF-7 breast cancer cell proliferation. The
LTX-diol isomers isolated by HPLC were
taken to dryness under nitrogen at 50°C,
weighed, and redissolved at known concentra-
tions in 100% ethanol for the cell prolifera-
tion assays as described above. Brieﬂy, MCF-7
cells grown as described above were treated
with a range of LTX-diol or iso-LTX-diol con-
centrations (0.1–10 µg/mL), and cell number
was determined 7 days after treatment, as
described previously (Markaverich et al.
2002a, 2002b). The isomers had equivalent
biologic activity in the MCF-7 cell prolifera-
tion assay; therefore, the mixture was used for
the remaining studies. 
LTX-diol competition for [3H]estradiol
binding to ER and type II sites in rat uterine
nuclear fractions. Earlier studies on partially
purified ground corncob extracts containing
the mitogenic activity revealed that these
preparations did not compete for [3H]estradiol
binding to ER or nuclear type II [3H]estradiol
binding sites. This was later confirmed with
pure preparations of synthetic THF-diol
(Markaverich et al. 2002a, 2002b). Thus, we
suspected that the biologic effects of the
LTX-diols were probably not mediated via
direct interactions with either ER or the
nuclear type II sites because the LTX-diols are
structurally related to the THF-diols. To
directly evaluate these possibilities, we assessed
LTX-diol competition for [3H]estradiol bind-
ing to ER or type II sites (Markaverich et al.
2002a, 2002b). Brieﬂy, adult female Sprague-
Dawley rats were ovariectomized and
implanted with 20-µg estradiol-containing
beeswax pellets to promote nuclear ER reten-
tion and stimulate nuclear type II sites
(Markaverich et al. 2002b). Seven days after
treatment, the uteri were removed from these
animals, stripped of extraneous tissues,
weighed, and chilled in ice-cold saline before
analysis. For ER competition studies, rat uter-
ine tissue was homogenized in 10 mM Tris,
1.5 mM EDTA, and 0.1 mM dithiothreitol,
pH 7.4 at 22°C, and uterine nuclear suspen-
sions were incubated at 37°C for 30 min in
the presence of 10 nM [3H]estradiol ±
0.01–10 µM LTX-diol or diethylstilbestrol
(DES) under conditions that measure only
[3H]estradiol binding to ERs (Markaverich
et al. 1981). For type II site competition stud-
ies, uterine tissue was homogenized in TE
buffer (10 mM Tris, 1.5 mM EDTA) and
nuclear suspensions were incubated at 4°C ×
60 min in the presence of 30 nM [3H]estradiol
± 0.00015–30 µM LTX-diol or luteolin (a
competitive inhibitor of type II sites but not
ERs) under conditions that measure [3H]estra-
diol binding to type II sites but not occupied
ERs. After incubation, the nuclear suspensions
for ER or nuclear type II site assays were
washed 3 times by resuspension and centrifu-
gation (800 × g × 7 min) in 1 mL TE buffer,
and the final washed pellets were extracted
with 1 mL 100% ethanol. Radioactivity in the
ethanol extract was determined by liquid scin-
tillation spectrometry (Markaverich et al.
1981). [3H]Estradiol binding in the absence of
competitor (controls) was approximately
10,000 cpm for ERs and 30,000 cpm for
type II sites. Results were expressed as the per-
centage of [3H]estradiol bound in the presence
of the indicated concentrations of LTX-diol,
DES, or luteolin relative to the vehicle control
(100%).
Statistical analyses. We analyzed data from
cell proliferation assays and animal cycling
studies (body weights, ﬂuid consumption) sta-
tistically by analysis of variance (ANOVA) and
Tukey’s test on the treatment means using
InStat (GraphPad Software Inc., San Diego,
CA). The data recorded from the behavioral
tests for male sexual behavior (data not shown)
were compared using Kruskal-Wallis ANOVA
followed by Dunn’s method for post hoc com-
parison using Graph Pad Prism software, ver-
sion 4 (Graph Pad Software Inc.). 
Results
Purification of mitogenic agents in ground
corncob extract. HPLC analysis of an ethyl
acetate extract of ground corncob animal bed-
ding separated two major peaks of mitogenic
activity (peaks I and II), as shown in Figure 2.
Peak I was previously identiﬁed as a mixture of
the THF-diol isomers (Figure 1) shown to dis-
rupt male and female endocrine function
in vivo (Mani et al. 2005; Markaverich et al.
2002a, 2002b). We purified and identified
peak II in the present study. Preliminary stud-
ies revealed that the peak II component did
not contain compounds sufﬁciently volatile for
GC-MS without derivatization. Therefore, the
material was derivatized with BSTFA and ana-
lyzed by GC-MS. Figure 3A represents the
total ion chromatogram obtained by GC-MS
analysis showing two major peaks that eluted
from the column. When run in the electron
ionization mode, the ﬁrst peak at 14.53 min
generated the spectra shown in Figure 3B.
Positive chemical ionization data (not shown)
determined that the molecular weight of the
BSTFA-unknown derivative was 530 amu.
Catalytic hydrogenation indicated the presence
of one carbon–carbon double bond. Reaction
with methanolic HCl before derivatization
with BSTFA produced a new peak with a mol-
ecular weight consistent with the replacement
of one TMS group with a methyl group. This
observation indicated the presence of a
COOH group in the unknown because car-
boxylic acids are readily esterified in either
methanolic HCl or BSTFA. Further inspection
of the spectral data suggested that the com-
pound was a 9,10-diol derived from linoleic
acid. This compound would have a molecular
weight of 530 amu when derivatized with
BSTFA and would be expected to fragment
between the 9 and 10 positions (Murphy
Markaverich et al.
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213, and between carbons 10 and 11, produc-
ing m/z 419. Loss of 90 amu [–Si(CH3)3OH)]
from the m/z 419 accounts for the m/z 329
result. The unknown in Figure 3B was tenta-
tively identified as LTX-diol. This was con-
ﬁrmed with a match of spectra in the literature,
and the compound has a molecular weight of
314 amu. (Draper and Hammock 2000;
Sugiyama et al. 1987).
Synthesis and purification of LTX-diol
and iso-LTX-diol. For conﬁrmation of struc-
ture and biologic activity, we synthesized an
isomeric LTX-diol mixture as described in
“Materials and Methods.” This procedure
involved forming the epoxides from linoleic
acid and then opening the epoxide ring to
generate the vicinal diols. A diepoxide is also
formed that will cyclize and generate the
THF-diol that we identified from corncob
bedding (Mani et al. 2005; Markaverich et al.
2002a, 2002b). Unreacted linoleic acid and
by-products of mCPBA not removed by
extraction were all present in the reaction
mixture containing LTX-diol and iso-LTX-
diol (Figure 4A; peaks at 13.99 and
14.07 min). Solid-phase extraction on
reverse-phase C18 cartridges (Waters Corp.)
removed the straight-chain hydroxy fatty
acids and separated LTX-diol and iso-LTX-
diol from the other components (Figure 4B).
Thus, we were able to purify an LTX-diol and
iso-LTX-diol isomer mixture to near homo-
geneity by this procedure. The LTX-diol and
iso-LTX-diol isomers were separated by
HPLC (Figure 5), and the individual isomers
were used for the cell proliferation assays.
Effects of synthetic LTX-diol and iso-LTX-
diol on MCF-7 cell proliferation. LTX-diol
and iso-LTX-diol puriﬁed by HPLC (Figure 5)
were added to tissue culture medium in 2 µL
ethanol such that the ﬁnal concentration varied
from 0.1 to 10 µg/mol (0.32–1.6 µM;
Figure 6). Both isomers stimulated MCF-7
human breast cancer cell proliferation to equiv-
alent degrees at concentrations ranging from
0.32 to 1.6 µM. These concentrations of the
LTX-diols are > 400-fold lower than those
doses generally characterized as toxic in insect
cell cultures in vitro (Hayakawa et al. 1986;
Sisemore et al. 2001). Thus, at these lower
concentrations, the LTX-diols are mitogenic,
and we anticipate that the compounds will
stimulate the proliferation of hormone-depen-
dent and hormone-independent breast and
prostate cancer cells if their mechanism of
action is similar to that of the THF-diols
(Mani et al. 2005; Markaverich et al. 2002a,
2002b). Although LTX-diol identiﬁed as the
peak II component isolated from ground corn-
cob in this study is an auto-oxidation product
of linoleic acid in animals, a cytosolic epoxide
hydrolase can metabolize the epoxy fatty esters
to their vicinol diols (Halankar et al. 1989).
This same enzyme exists in plants, as well (Blee
and Shuber 1992), and therefore, it is feasible
that epoxy fatty acids, known to be abundant
in the plant kingdom, may be metabolized to
vicinol diols.
LTX-diol competition for ER and nuclear
type II sites. Data in Figure 7 show that the
LTX-diol mixture failed to compete for
[3H]estradiol binding to rat uterine nuclear
ER (Figure 7A) or nuclear type II sites
(Figure 7B). These data are consistent with
results obtained with partially puriﬁed ground
corncob extracts containing both the THF-
diols and LTX-diols (Markaverich et al.
2002a, 2002b). Thus, it is unlikely that the
effects of these compounds on cellular prolif-
eration or biologic response in vivo in male or
female rats involve binding interactions with
either ER or type II sites.
Effects of LTX-diols on the estrous cycle of
female rats and male sexual behavior. Adult
female rats displayed normal 4.6 ± 0.25 day
estrous cycles for 30 days when maintained on
tap water/5.0% Tween 80 vehicle (Figure 8).
Administration of LTX-diols to these animals
at a daily dose level of >> 0.8 mg/kg body
weight (2 µg/mL drinking solution) for
30 days disrupted the estrous cycle in 100% of
the animals (Figure 8); this disruption was evi-
dent within the ﬁrst 3 or 4 days after treatment
and was sustained for the 30-day treatment
period. These animals displayed vaginal smears
resembling atypical sustained metestrus as
described for THF-diols (Markaverich et al.
2002a, 2002b). Consequently, these atypical
Leukotoxin diol and breast cancer
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Figure 3. GC-MS analysis of HPLC peak II component isolated from ground corncob. An aliquot of the
pooled peak II fractions (Figure 1) was derivatized with BSTFA to generate the trimethylsilyl ether and
chromatographed on a DB-1 column as described in “Materials and Methods.“ (A) Total ion chromatogram
for this sample. (B) Electron ionization spectrum for peak at 14.53 min. 
Figure 4. GC-MS analysis of synthetic LTX-diol. The LTX-diol mixture, synthesized as described in
“Materials and Methods,” was derivatized and analyzed as described in Figure 2. (A) Total ion chromatogram
of the sample before cleanup on C18 reverse-phase resin. (B) Total ion chromatogram after cleanup on the
C18 reverse-phase resin. 
Figure 5. Separation of LTX-diol isomers by
reverse-phase HPLC. The synthetic mixture of LTX-
diol and iso-LTX-diol shown in Figure 3 was sepa-
rated and detected as described in “Materials and
Methods.” 
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Figure 6. Effects of the LTX-diol isomers on MCF-7
human breast cancer cells grown for 7 days in the
absence or presence of of LTX-diol or iso-LTX-diol.
Cell number was determined by hemocytometer
counts. 
*Significantly different from controls or other LTX-diol
dose levels (p < 0.001). Data represent the mean ± SEM for
at least 12 determinations. smears were not appropriate for differential
cell count analyses to deﬁne a potential mech-
anism of action of these compounds; we are
currently performing detailed mechanistic
studies with these compounds in vitro. We
found no significant treatment effects on
body weights (controls = 265 ± 8.7 g; LTX-
diol = 243 ± 4.8 g) or fluid consumption
(controls = 38.85 mL/day/rat; LTX-diol =
38.75 mL/day/rat). Based on ﬂuid consump-
tion, the LTX-diol–treated female rats con-
sumed >> 0.7 ± 0.072 mg LTX-diol/kg body
weight per day. This higher dose level than
that used for the THF-diols (>> 0.3 mg/kg
body weight per day) was due to the differ-
ence in ﬂuid volume consumption by the ani-
mals in the two studies (Markaverich et al.
2002a, 2002b).
Treatment of established breeder males
with the LTX-diol drinking solution for
1–4 weeks had no signiﬁcant effect on mount-
ing, intromission, ejaculation, ejaculation
latency, or grooming behavior (data not
shown). These results are in sharp contrast to
studies with similar doses of THF-diols, which
completely blocked male sexual behavior
(Mani et al. 2005; Markaverich et al. 2002a
2002b). These ﬁndings suggest that sex differ-
ences may exist in responses to the THF-diols
and the LTX-diols, or that higher doses of the
LTX-diols are required to block male sexual
behavior. More deﬁnitive dose–response and
time studies to address these possibilities are in
progress. Although we have not directly quan-
tified the levels of LTX-diol or THF-diol in
corncob bedding by GC-MS, it is clear from
HPLC analysis of a number of corncob
extracts that the concentration of these disrup-
tor/mitogenic agents in different lots or vari-
eties of corncob, and genetically engineered
corn, vary significantly (Markaverich BM,
Alejandro MA, Crowley JR, unpublished
data). Thus, these differences in the relative
levels of these compounds in ground corncob
may serve to limit or enhance exposure and
potential toxicity.
Discussion
Previous studies from our laboratories
described the presence of an endocrine disrup-
tor in ground corncob bedding that blocked
male and female sexual behavior and cyclicity
(Mani et al. 2005; Markaverich et al. 2002a,
2002b) in rats. The endocrine-disruptive
activity copuriﬁed on HPLC with two peaks
of mitogenic activity, leading us to believe that
the mitogenic agents and endocrine disruptors
were the same compounds. We identiﬁed the
ﬁrst mitogenic HPLC peak component(s) as
the THF-diols (Figure 1). These compounds
were synthesized and shown to stimulate
MCF-7 breast cancer cell proliferation in vitro
and block reproductive behavior and cyclicity
in rats at doses in the range of 0.35–0.7 mg/kg
body weight (Mani et al. 2005; Markaverich
et al. 2002a, 2002b). In the present study we
identified a second pair of mitogenic agents
(LTX-diols) in HPLC peak II (Figure 2) from
corncob bedding that also disrupt the estrous
cycle of rats (Figure 8). The LTX-diols maxi-
mally stimulate MCF-7 human breast cancer
cell proliferation at doses (0.1 µg/mL) that are
50-fold lower than those of the THF-diols
(5 µg/mL), suggesting that the compounds
have significantly different mitogenic activi-
ties (Markaverich et al. 2002a). The LTX-
diols were approximately equivalent to
THF-diols [0.3 mg/kg/day (Markaverich
et al. 2002a)] in terms of endocrine-disruptive
activities. When female rats were given the
vehicle for 30 days, they displayed normal
estrous cycles (4.6 ± 0.25 days); however,
consumption of >> 0.7 mg/kg LTX-diol and
iso-LTX-diol disrupted cyclicity within 3 or
4 days, and this suppression was sustained
throughout the 30-day treatment period.
Vaginal smears taken from the LTX-diol–
treated animals indicated that a prolonged
atypical metestrous state was induced, as pre-
viously observed for the THF-diols (Mani
et al. 2005; Markaverich et al. 2002a, 2002b).
No signiﬁcant treatment effects on ﬂuid con-
sumption or body weights of the animals were
observed, suggesting that systemic toxicity
was not a problem.
The doses of LTX-diols required to block
estrus in the present studies were equivalent to
the dose level of THF-diols administered to
adult male and female rats (0.35–0.75 mg/kg
body weight) to block sexual behavior and
cyclicity (Mani et al. 2005; Markaverich et al.
2002a, 2002b). We suspect the LTX-diols and
THF-diols are acting through similar mecha-
nisms. The actual concentration of THF-diols
and LTX-diols administered in all of these
studies was 2 µg/mL of the Tween 80 drinking
solution. The difference in daily doses deliv-
ered to the male and female rats in the various
studies is attributed to differences in body
weights and fluid consumption volumes.
Because we observed a virtual 100% block of
estrous cyclicity by LTX-diols in the present
studies, and of male and female sexual behav-
ior and cyclicity in response to the THF-diols
in previous studies (Mani et al. 2005;
Markaverich et al. 2002a, 2002b), the actual
concentration of these compounds required to
block biologic response may be lower than that
used here. Once we have sufﬁcient quantities
of the compounds on hand, extensive dose
studies will be completed with the individual
compounds alone and combined to determine
whether synergistic interactions exist.
Surprisingly, the LTX-diol isomers did not
block male sexual behavior in the present stud-
ies. This is in marked contrast to data obtained
with the THF-diols (Mani et al. 2005). At pre-
sent, we have no explanation for this discrep-
ancy other than that there may be dose or sex
differences with respect to the response to the
LTX-diols and/or differences in the biologic
fate of these compounds. It is clear that both
the LTX-diols (Figure 8) and THF-diols
(Markaverich et al. 2002a) block estrous cyclic-
ity. Housing adult female rats on corncob bed-
ding blocked female sexual behavior (lordosis),
but we have not evaluated the effects of the
LTX-diols on this parameter. Studies are under
way to delineate effects of the LTX-diols and
THF-diols on male and female sexual behavior
and to deﬁne the biologic fate and mechanism
of action of these compounds in both sexes.
The THF-diols are very closely related to the
LTX-diols (both likely evolving from linoleic
acid pathways), and we suspect that these
compounds are modulating gonadotrophic-
hormone–releasing hormone (GHRH) release
through nitrous oxide (NO)–dependent path-
ways. Leukotoxins stimulate NO release from
Markaverich et al.
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Figure 7. Synthetic LTX-diol competition for ER (A) and nuclear type II sites (B), as described in “Materials
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Figure 8. Effects of LTX-diols on the estrous cycle of
adult female rats (n = 8). See “Materials and
Methods” for details. mammalian cells (Ishizaki et al. 1995), and
NO mediates male and female sexual behavior
(Hull et al. 1994; Ishizaki et al. 1995) via stim-
ulating GHRH release from hypothalamic
neurons (Moses 1999). Therefore, it is possible
that the THF-diols and LTX-diols disrupt
endocrine function via hypothalamic pathways
involving GHRH release. We are currently
exploring these possibilities.
Similarly, we do not yet understand the
mechanisms underlying the mitogenic activi-
ties of the THF-diols or LTX-diols in human
cancer cells in vitro or in vivo. However, in vivo
pathways may involve the modulation of hypo-
thalamic–pituitary–gonadal axes and lipid
metabolism as well. If the THF-diols or LTX-
diols modulate luteinizing-hormone–releasing
hormone release via pathways related to NO
synthase, phospholipase A (PLA), cyclooxyge-
nase (COX), or lipoxygenase (LOX), the com-
pounds may directly or indirectly control
breast or prostate cancer growth and prolifera-
tion via modulation of gonadotropin release
and/or ovarian or testicular steroidogenesis.
Effects on male and female sexual behavior and
cyclicity are certainly consistent with this
notion (Mani et al. 2005; Markaverich et al.
2002a, 2002b). In addition, although the
THF-diols and LTX-diols on ground corncob
extracts stimulate estrogen-dependent (MCF-7
cells) cell proliferation, the compounds also
stimulate cell proliferation in estrogen-inde-
pendent breast cancer (MDA-MD-231 cells)
and prostate cancer (LNCap vs. PC-3 cells) cell
lines (Markaverich et al. 2002a, 2002b)
in vitro. These ﬁndings imply direct effects on
nonestrogenic cellular pathways controlling cell
proliferation, as well. An association also exists
between COX activity and prostaglandin E2
induction of aromatase in MCF-7 breast can-
cer cells. Thus, the potential exists for generat-
ing estrogens required for cell proliferation
(Brueggemeir et al. 2001; Richards et al.
2002). Because THF-diols and/or LTX-diols
may affect COX pathways involved in
prostaglandin synthesis, it is also possible that
these compounds modulate aromatase.
Tetradecanoyl phorbol acetate (TPA) induc-
tion of COX activity in MDA-MB-231 cells
results in enhanced proliferation (Brueggemeir
et al. 2001; Richards et al. 2002), and the
THF-diols and /or LTX-diols may also control
the proliferation of ER-negative cells by modu-
lating COX activity. The dose–response data
in Figure 5 are certainly consistent with the
regulation of enzymatic pathways, where lower
doses might be expected to stimulate enzy-
matic activity and higher concentrations may
inhibit enzymatic activity via substrate inhibi-
tion. Alternatively, there may be intracellular
receptors for the THF-diols and LTX-diols
that would explain their mitogenic activities at
lower concentrations and inhibitory properties
at higher concentrations (Markaverich et al.
2002a, 2002b). Classical bell-shaped dose–
response curves are typically seen for com-
pounds such as estradiol that mediate their
effects via ER binding mechanisms (Clark and
Peck 1979). Thus, it is certainly possible that
intracellular receptors exist for the THF-diols
and/or LTX-diols, and we will be evaluating
these possibilities.
Epidermal growth factor (EGF) stimula-
tion of cell proliferation involves membrane-
associated PLA-mediated release of arachidonic
acid and linoleic acids from the cell membrane.
The conversion of these fatty acids to
prostaglandins (Nolan et al. 1988) or linoleic
acid metabolites [9-hydroxyoctadecadienoic
acid (9-HODE), 12-HODE, and 13-HODE]
mediates EGF stimulation of [3H]thymidine
incorporation into DNA (Glasgow and Eling
1990, 1994), cell cycle transition, and apopto-
sis (Durgam and Fernandes 1997; Kachhap
et al. 2000; Tong et al. 2002). Breast cancer
specimens contain higher concentrations of
PLA than do benign breast tissues, and low
PLA activity is associated with longer disease-
free interval and survival even though no rela-
tionship was noted between PLA and ER or
progesterone receptor status (J. Yamashita
et al. 1995; S. Yamashita et al. 1993, 1994).
In MCF-7, MCF-10, and MDA-MB-231
human breast cancer cells, LOX, but not
COX, inhibitors block EGF/transforming
growth factor α stimulation of 12-HODE,
and 13-HODE production and cellular pro-
liferation (Natajaran et al. 1997; Reddy et al.
1997). A number of LOX inhibitors includ-
ing nordihydroguaiaretic acid, baicalein, and
Rev-5901 inhibit MCF-7 and MDA-MB-231
cell proliferation and induce apoptosis. LOX
products [5-eicosatrienoic acid (5-HETE),
12-HETE] reverse these effects (Natajaran
et al. 1997). EGF stimulation of MCF-7 cell
proliferation causes a dose-dependent increase
in the formation of LOX products, including
12-HETE (Tong et al. 2002). Thus, LOX
products (HODEs, HETEs) stimulate prolif-
eration of these cells. THF-diols and LTX-
diols are derived from linoleic acid pathways
that generate HODEs and HETEs. It is pos-
sible that the THF-diols and LTX-diols mod-
ulate cellular proliferation by controlling the
synthesis of these linoleic acid metabolites
and/or by mimicking these compounds as
mitogenic agents.
In addition to their effects on endocrine-
regulated pathways and tumor cell prolifera-
tion (Mani et al. 2005; Markaverich et al.
2002a, 2002b), exposure to THF-diols and
LTX-diols may cause additional health prob-
lems. Hydroxy fatty acids are substrates for
liver glucuronosyltransferases (Jude et al. 2001;
Street et al. 1996). Although this pathway is a
probable means of detoxiﬁcation of dihydroxy
fatty acids, compounds such as LTX-diol are
subject to inhalation and may be trapped in
the lung as the free hydroxy fatty acids.
Farmers are at high risk for respiratory prob-
lems and account for 30% of adults suffering
from respiratory illness. Risk factors are
believed to include exposure to fungus, molds,
pesticides, organic dust from a variety of areas
including animal bedding, and silicosis (Kansas
State University Cooperative Extension Service
1981; North Carolina Cooperative Extension
Service 1995). Uncharacterized chemical
agents in these materials may include the LTX-
diols and THF-diols. In addition to being used
as bedding for small animals, ground or milled
corncob is also used as adsorbent for chemical
spills, a polishing agent for metals, and a pesti-
cide carrier for insects such as spider mites and
ﬁre ants. This product is also used as cat litter.
Thus, exposure of the general public to toxic
agents in ground corncob is likely. Clearly,
these fatty acid diols stimulate breast cancer
cell proliferation in vitro and disrupt reproduc-
tive function in rats at relatively low concentra-
tions. Sustained exposure to such compounds
may represent a signiﬁcant health hazard.
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